PD-1 over-expression has been implicated in diverse array of tumor types because of its participation in signaling pathways regulating attenuated CD8+ T cell function and enhanced Treg cell activity, which creates an inhibitory environment in the tumors. Here, CD8A is linked to neoplasm.